Senior Investigator
Division of Cancer Epidemiology, Infections and Immunoepidem
National Cancer Institute
United States of America
Dr. Hildesheim was Chief of the Infections and Immunoepidemiology Branch from 2008-2017. He received his Ph.D. in epidemiology from The Johns Hopkins School of Hygiene and Public Health in 1991 and has been at the NCI since 1987. Dr. Hildesheim's research focuses on understanding host and viral factors involved in the pathogenesis of DNA virus-related tumors and in the evaluation of efficacy and underlying immunological mechanisms associated with licensed prophylactic HPV vaccines
Cervical Cancer; HPV Vaccines; Nasopharyngeal Cancer